# Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.

> **NCT00319501** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 234 (actual)

## Conditions studied

- Seizures
- Epilepsies, Partial
- Epilepsy, Complex Partial
- Epilepsy, Generalized
- Epilepsy

## Interventions

- **DRUG:** Placebo
- **DRUG:** Vanquix Auto-Injector (Diazepam Injection)

## Key facts

- **NCT ID:** NCT00319501
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319501, "Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00319501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*